CN Stock MarketDetailed Quotes

600420 Shanghai Shyndec Pharmaceutical

Watchlist
  • 11.32
  • +0.05+0.44%
Not Open Mar 11 15:00 CST
15.18BMarket Cap14.03P/E (TTM)

Shanghai Shyndec Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Shyndec Pharmaceutical Q4 2024 Estimates Date

Currency：CNYMar 28, 2025

Estimate YoY
Revenue
2.87B
-1.21%
EPS
0.11
+22.22%
Analyst Rating
Strong Buy

Mar 11, 2025

Shanghai Shyndec Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.409B--
Mar 28, 20252024/Q4-- / 2.873B--
Oct 29, 20242024/Q32.633B / 2.955B--
Aug 28, 20242024/Q22.837B / 3.196B--
Apr 30, 20242024/Q13.123B / 3.343B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.409B--
Mar 28, 20252024/Q4-- / 2.873B--
Oct 29, 20242024/Q32.633B / 2.955B--
Aug 28, 20242024/Q22.837B / 3.196B--
Apr 30, 20242024/Q13.123B / 3.343B--

Unlock Free Earnings Estimates

Shanghai Shyndec Pharmaceutical Earnings Reports

  • Sinopharm Hyundai: 2024 Annual Performance Forecast

    Jan 19 11:00 ET

  • 2024 Annual Results Forecast

    Jan 19 11:00 ET

  • Sinopharm Hyundai: third quarter report 2024

    Oct 28, 2024 12:00 ET

  • Third Quarter Report 2024

    Oct 28, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Hanshow Technology
    301275
    66.92 +143.35%
    Yong Jie New Material
    603271
    46.23 +124.42%
    ZZT
    873726
    38.71 +29.99%
    BEOKA
    870199
    36.98 +23.76%
    Geovis Insighter Technology
    920116
    126.20 +21.91%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Mar 11, 2025

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Cosmetics Concept
    Cosmetics Concept
    Intraday+2.33%
    Medical Beauty Concept
    Medical Beauty Concept
    Intraday+1.47%
    Macrobiotic NMN
    Macrobiotic NMN
    Intraday+0.85%